Esophagus Cancer

The European Commission has approved Merck & Co Inc's (NYSE: MRK) Keytruda in combination with platinum- and fluoropyrimidine-based chemotherapy as first-line treatment of Esophageal Carcinoma or Gastroesophageal Junction (GEJ) Adenocarcinoma. The approval covers patients...